GABAPENTIN
- Product NDC
- 31722-092
- 11-digit product format
- 317220092
- Labeler code
- 31722
- Product ID
- 31722-092_360950f4-eef0-54cb-e063-6394a90aa5d6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA218075
- Marketing category
- ANDA
- Marketing start
- 2024-02-26
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GABAPENTIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 1806380, 1806382 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-092-90 | GABAPENTIN | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-092 | GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.] | 2 | Current NDC, 1 package rows | 20250528_0ce53f62-1738-43f4-9a2e-c5dc42a91d09.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-092-90 | 31722009290 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-092-90) | 2024-02-26 | No | No | Historical |